» Articles » PMID: 12618752

C/EBP Family Transcription Factors Are Degraded by the Proteasome but Stabilized by Forming Dimer

Overview
Journal Oncogene
Date 2003 Mar 6
PMID 12618752
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

CCAAT/enhancer-binding protein (C/EBP) family transcription factors are critical for transcription of several genes involved in tissue development and cellular function, proliferation, and differentiation. Here we show that inhibitory/regulatory C/EBP family proteins, Ig/EBP (C/EBPgamma) and CHOP (C/EBPzeta), but not positively functioning NF-IL6 (C/EBPbeta), are constitutively multiubiquitinated and subsequently degraded by the proteasome. In addition, ubiquitination and degradation of these proteins are suppressed by forming dimer through their leucine zipper domains. Deletion of leucine zipper domain in NF-IL6 caused the loss of its homodimerization activity and the degradation of protein by the ubiquitin-proteasome system. In addition, Ig/EBP with its leucine zipper domain substituted for that of NF-IL6 formed homodimer and was stabilized. These observations suggest that mammalian cells equip a novel regulatory system abrogating the excess C/EBP family transcription factors bereft of dimerizing partner.

Citing Articles

Unleashing the power of peptides in prostate cancer immunotherapy: mechanism, facts and perspectives.

Li X, Yang F, Wang M, Huang X, Zeng X, Zhou L Front Pharmacol. 2025; 16:1478331.

PMID: 40078274 PMC: 11897510. DOI: 10.3389/fphar.2025.1478331.


An Effective Computational Method for Predicting Self-Interacting Proteins Based on VGGNet Convolutional Neural Network and Gray-Level Co-occurrence Matrix.

Chu D, An J, Nie X Evol Bioinform Online. 2024; 20:11769343241292224.

PMID: 39464790 PMC: 11503870. DOI: 10.1177/11769343241292224.


PPA1 promotes adipogenesis by regulating the stability of C/EBPs.

Wu Y, Sun Y, Song Y, Wang J, Han Y, Yang N Cell Death Differ. 2024; 31(8):1044-1056.

PMID: 38762596 PMC: 11303681. DOI: 10.1038/s41418-024-01309-2.


CCAAT/Enhancer-Binding Proteins in Fibrosis: Complex Roles Beyond Conventional Understanding.

Wang L, Feng J, Deng Y, Yang Q, Wei Q, Ye D Research (Wash D C). 2022; 2022:9891689.

PMID: 36299447 PMC: 9575473. DOI: 10.34133/2022/9891689.


Anticancer Activity of ST101, A Novel Antagonist of CCAAT/Enhancer Binding Protein β.

Darvishi E, Ghamsari L, Leong S, Ramirez R, Koester M, Gallagher E Mol Cancer Ther. 2022; 21(11):1632-1644.

PMID: 36121385 PMC: 9630826. DOI: 10.1158/1535-7163.MCT-21-0962.